SCHEDULE: Squadron Master Fund Discloses 3% Stake in Palisade Bio
Beneficial Ownership Disclosure
Squadron Master Fund LP, along with related entities and individuals, has disclosed a 3.0% passive beneficial ownership stake in Palisade Bio, Inc.
Summary
- Squadron Master Fund LP, Squadron Capital Management LLC, Matthew Sesterhenn, and William Blank collectively reported beneficial ownership of 4,500,000 shares of Palisade Bio, Inc. common stock.
- This ownership represents 3.0% of the outstanding common stock of Palisade Bio, Inc.
- The percentage is based on 149,003,210 shares of common stock outstanding as of November 5, 2025, as reported by the Issuer in its Form 10-Q.
- All reporting persons share both voting and dispositive power over the 4,500,000 shares.
- The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral disclosure, as it primarily reports a passive ownership stake without providing operational or financial performance updates. The presence of a new institutional investor could be seen as mildly positive.
Positives
- The disclosure of a new institutional investor, Squadron Master Fund LP, holding a 3.0% stake could signal increased institutional interest and confidence in Palisade Bio, Inc.
Future Outlook
NA
Industry Context
StockSavvy.ai notes that the disclosure of a new passive institutional stake, even at 3.0%, can sometimes be interpreted by the market as a positive signal, indicating that professional investors see value in the company. This type of filing is a standard regulatory requirement for investors acquiring more than 5% of a company's stock (or less for certain institutional investors) without the intent to influence control.
Stakeholder Impact
- Shareholders: The disclosure of a new institutional investor holding a 3.0% stake may influence investor sentiment and potentially the stock price.
Key Dates
| Date | Description |
|---|---|
| 2025-11-05 | Date as of which 149,003,210 shares of common stock were outstanding, used for ownership percentage calculation. |
| 2025-12-31 | Date of event which requires the filing of this statement. |
| 2026-02-17 | Date the Schedule 13G Amendment No. 1 was signed by the reporting persons. |
Keywords
Palisade Bio, Squadron Master Fund, Beneficial Ownership, Schedule 13G, Common Stock, Institutional Investor
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.